| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
a Department of Urology, College of Physicians and Surgeons of Columbia University, New York, New York 10032
Penile tissue was obtained from adult rats and from human patients undergoing penile prosthesis implantation. Analysis of the forms of VEGF transcripts was performed using a reverse transcription-polymerase chain reaction technique with primer pairs derived from the first and eighth exon of the VEGF gene. The expression levels of the various isoforms in the rat penis were then quantified using RNase protection assays. Four previously described splice variants of VEGF mRNA (VEGF 120, 144, 164, 188) were detected in rat and human penile tissues. In contrast to what is seen in the rat lung, where the most abundant form of VEGF mRNA is the 188 splice isoform, VEGF 164 is the most abundant transcript detected in the penis. Finally, sequence analysis of numerous VEGF cDNA clones obtained from the rat penis demonstrated the presence of a previously undescribed VEGF splice variant that could give rise to a protein of 110 amino acid residues (VEGF 110, GenBank accession no. AF080594). In summary, a number of VEGF mRNA isoforms are expressed in the rat and human penis, with the splice variant encoding a 164-amino acid protein present in greatest abundance. This study is a prelude to attempts to genetically manipulate VEGF expression in the penis as a therapy for erectile dysfunction.
Erectile dysfunction is often associated with problems in vascular perfusion to the erectile components of the penis. In order to better understand the factors that control vascular formation and perfusion in the erectile tissues of the penis, we have begun to characterize the expression of vascular endothelial growth factor (VEGF) in penis tissues. VEGF is one of several polypeptides that have significant angiogenic activity in vitro and in vivo. Extensive characterization of the VEGF gene and its products has shown that several different mature mRNA transcripts exist, originating from alternative splicing of the basic VEGF transcript. These variant transcripts can encode peptides with different biological activities.
2 Correspondence: Ridwan Shabsigh, Department of Urology, Columbia-Presbyterian Medical Center, Atchley Pavilion, 11th Floor, 161 Fort Washington Ave., New York, NY 10032. FAX: 212 305 0126;rs66{at}columbia.edu
This article has been cited by other articles:
|
|
 |
|
  L. E. Burt, M. S. Forbes, B. A. Thornhill, S. C. Kiley, and R. L. Chevalier Renal vascular endothelial growth factor in neonatal obstructive nephropathy. I. Endogenous VEGF Am J Physiol Renal Physiol, January 1, 2007; 292(1): F158 - F167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Carpenter, S. Schomberg, and K. R. Stenmark Endothelin-mediated increases in lung VEGF content promote vascular leak in young rats exposed to viral infection and hypoxia Am J Physiol Lung Cell Mol Physiol, December 1, 2005; 289(6): L1075 - L1082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.N. Mowa, S. Jesmin, I. Sakuma, S. Usip, H. Togashi, M. Yoshioka, Y. Hattori, and R. Papka Characterization of Vascular Endothelial Growth Factor (VEGF) in the Uterine Cervix over Pregnancy: Effects of Denervation and Implications for Cervical Ripening J. Histochem. Cytochem., December 1, 2004; 52(12): 1665 - 1674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Vucenik, A. Passaniti, M. I. Vitolo, K. Tantivejkul, P. Eggleton, and A. M. Shamsuddin Anti-angiogenic activity of inositol hexaphosphate (IP6) Carcinogenesis, November 1, 2004; 25(11): 2115 - 2123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Musicki, M. A. Palese, J. K. Crone, and A. L. Burnett Phosphorylated Endothelial Nitric Oxide Synthase Mediates Vascular Endothelial Growth Factor-Induced Penile Erection Biol Reprod, February 1, 2004; 70(2): 282 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rajasekaran, A. Kasyan, W. Allilain, and M. Monga Ex Vivo Expression of Angiogenic Growth Factors and Their Receptors in Human Penile Cavernosal Cells J Androl, January 1, 2003; 24(1): 85 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Onimaru, Y. Yonemitsu, M. Tanii, K. Nakagawa, I. Masaki, S. Okano, H. Ishibashi, K. Shirasuna, M. Hasegawa, and K. Sueishi Fibroblast Growth Factor-2 Gene Transfer Can Stimulate Hepatocyte Growth Factor Expression Irrespective of Hypoxia-Mediated Downregulation in Ischemic Limbs Circ. Res., November 15, 2002; 91(10): 923 - 930. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gomez, C. Simon, J. Remohi, and A. Pellicer Vascular Endothelial Growth Factor Receptor-2 Activation Induces Vascular Permeability in Hyperstimulated Rats, and this Effect Is Prevented by Receptor Blockade Endocrinology, November 1, 2002; 143(11): 4339 - 4348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rajasekaran, A. Kasyan, A. Jain, S.-W. Kim, and M. Monga Altered Growth Factor Expression in the Aging Penis: The Brown-Norway Rat Model J Androl, May 1, 2002; 23(3): 393 - 399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Podar, Y.-T. Tai, F. E. Davies, S. Lentzsch, M. Sattler, T. Hideshima, B. K. Lin, D. Gupta, Y. Shima, D. Chauhan, et al. Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration Blood, July 15, 2001; 98(2): 428 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Long, K. A. Burke, R. M. Bigsby, and K. P. Nephew Effects of the Xenoestrogen Bisphenol A on Expression of Vascular Endothelial Growth Factor (VEGF) in the Rat Experimental Biology and Medicine, May 1, 2001; 226(5): 477 - 482. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. G. Lee, H. J. Yoon, Z. Zhu, H. Link, Z. Wang, J. M. Gwaltney Jr., M. Landry, and J. A. Elias Respiratory Syncytial Virus Stimulation of Vascular Endothelial Cell Growth Factor/Vascular Permeability Factor Am. J. Respir. Cell Mol. Biol., November 1, 2000; 23(5): 662 - 669. [Abstract] [Full Text]
|
|
|
|
 |
|
 Z. Gluzman-Poltorak, T. Cohen, Y. Herzog, and G. Neufeld Neuropilin-2 and Neuropilin-1 Are Receptors for the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF) and of Placenta Growth Factor-2, but Only Neuropilin-2 Functions as a Receptor for the 145-Amino Acid Form of VEGF J. Biol. Chem., June 9, 2000; 275(24): 18040 - 18045. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
